Prostate cancer gene expression signature of patients with high body mass index

S. Sharad, A. Srivastava, S. Ravulapalli, P. Parker, Y. Chen, H. Li, G. Petrovics, A. Dobi*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Scopus citations


The goal of this study was to evaluate prostate cancer gene expression signatures associated with elevated body mass index (BMI). Global gene expression profiles of prostate tumor cells and matching normal epithelial cells were compared between patients with features of normal and high BMI at the time of radical prostatectomy. Knowledge-based analyses revealed an association of high BMI with altered levels of lipid metabolism and cholesterol homeostasis genes, such as stearoyl-CoA desaturase 1 (SCD1) and insulin-induced gene 1 (INSIG1), respectively, in prostate tumor cells. These genes were connected to known pathways of tumorigenesis revealed by the v-maf (musculoaponeurotic fibrosarcoma) oncogene homolog (MAF), notch receptor ligand, jagged 1 (JAG1) and the alanyl aminopeptidase (ANPEP/CD13) genes. This study highlighted that SCD1, a known target of statins, may have a mechanistic role in the recently noted beneficial effects of statin treatment in reducing biochemical recurrence of prostate cancer. An additional finding of our study is that some of the obesity-related genes were upregulated in tumor-matched normal cells within the high BMI group, when compared with normal cells within the normal BMI cohort.

Original languageEnglish
Pages (from-to)22-29
Number of pages8
JournalProstate Cancer and Prostatic Diseases
Issue number1
StatePublished - Mar 2011
Externally publishedYes


  • body mass index
  • gene expression
  • lipid metabolism
  • microarray
  • obesity
  • statins


Dive into the research topics of 'Prostate cancer gene expression signature of patients with high body mass index'. Together they form a unique fingerprint.

Cite this